2017 Buyer’s Guide

This buyer’s guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.



Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv



FDA Approves Abiomed's Impella RP System for Right Heart Failure

September 20, 2017 -- Abiomed, Inc. announced that it has received US Food and Drug Administration (FDA) premarket approval (PMA) for the Impella RP heart pump. The percu…

FORWARD PRO Postmarket Study Will Evaluate Medtronic's CoreValve Evolut Pro TAVR System

September 21, 2017 -- Medtronic announced a new postmarket clinical study that will evaluate its CoreValve Evolut Pro transcatheter aortic valve replacement (TAVR) system in e…

Long-Term Outcomes of PFO Closure Versus Medical Therapy after Stroke Compared in RESPECT Trial

September 19, 2017 -- In The New England Journal of Medicine (NEJM), Jeffrey L. Saver, MD, et al published findings from the RESPECT trial that investigated long-term outcomes…

Gore REDUCE Trial Evaluates Cardioform Device for PFO Closure

September 19, 2017 -- Lars Søndergaard, MD, et al published the findings from the Gore REDUCE Trial in The New England Journal of Medicine (NEJM;2017;377:1033 -- 1042).…

Featured Center




Current Supplement


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.